Molecular Endocrinology, Vol 9, 1583-1597, Copyright © 1995 by Endocrine Society

ARTICLES

Overlapping cis-acting elements located in the first intron of the gene for type I 3 beta-hydroxysteroid dehydrogenase modulate its transcriptional activity

SL Guerin, S Leclerc, H Verreault, F Labrie and V Luu-The
Laboratory of Molecular Endocrinology, Laval University Hospital Research Center, Ste-Foy, Quebec, Canada.

High levels of expression for the gene encoding human type I 3 beta- hydroxysteroid dehydrogenase (3 beta-HSDI) have been detected in placenta and skin but not in adrenals, which, however, express high levels of type II 3 beta-HSD. In this study, we addressed the issue of whether the differential pattern of cell-specific expression for type I 3 beta-HSD can be explained by the differential utilization of cis- acting regulatory elements present in the 3 beta-HSDI gene regulatory sequences. Deletion analyses indicated that removal of intron 1 strongly impaired the transcriptional activity directed by the 3 beta- HSDI basal promoter. Consequently, we focused our attention to the characterization of the 128 base pair first intronic sequence from the 3 beta-HSDI gene. A single protected region, designated the 3 beta I-A element, was identified by DNase I footprinting. Gel mobility shift assays indicated that at least four nuclear proteins with distinct biochemical and binding properties possess the ability to bind the 3 beta I-A element to produce four DNA-protein complexes (R1 to R4). However, the one producing R1, a 37-kilodalton protein that has been found in both human choriocarcinoma JEG-3 and adrenal cortex adenocarcinoma SW13 cells, as well as in all tested tissue culture cells, clearly accounts for the major 3 beta I-A-binding species. Site- directed mutagenesis provided the evidence that the 3 beta I-A element acts positively on the 3 beta-HSD-I gene promoter-mediated transcriptional activity upon transient transfection of both JEG-3 and SW13 cells. No homology has been found between the 3 beta I-A element and target sequences for other known transcription factors. In addition, of the four proteins binding the 3 beta I-A element, that producing R2 was identified as the positive transcription factor Sp1, whereas the identity of the remaining factors is still unknown. This is consistent with the presence of an Sp1 motif overlapping the 3 beta I-A element in intron 1, therefore pointing toward an important function played by this particular region in 3 beta-HSDI basal, but not cell- specific, gene expression.

This article has been cited by other articles:

				R. D. Kalmbach, S. F. Choumenkovitch, A. P. Troen, P. F. Jacques, R. D'Agostino, and J. Selhub A 19-Base Pair Deletion Polymorphism in Dihydrofolate Reductase Is Associated with Increased Unmetabolized Folic Acid in Plasma and Decreased Red Blood Cell Folate J. Nutr., December 1, 2008; 138(12): 2323 - 2327. [Abstract] [Full Text] [PDF]

				X. Xu, M. D Gammon, J. G Wetmur, M. Rao, M. M Gaudet, S. L Teitelbaum, J. A Britton, A. I Neugut, R. M Santella, and J. Chen A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1098 - 1102. [Abstract] [Full Text] [PDF]

				J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF]

				W. G Johnson, T. O Scholl, J. R Spychala, S. Buyske, E. S Stenroos, and X. Chen Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor for preterm delivery Am. J. Clinical Nutrition, March 1, 2005; 81(3): 664 - 668. [Abstract] [Full Text] [PDF]

				W. Wang, L. Wang, A. Endoh, G. Hummelke, C. L Hawks, and P. J Hornsby Identification of {alpha}-enolase as a nuclear DNA-binding protein in the zona fasciculata but not the zona reticularis of the human adrenal cortex J. Endocrinol., January 1, 2005; 184(1): 85 - 94. [Abstract] [Full Text] [PDF]

				L. Peng, Y. Huang, F. Jin, S.-W. Jiang, and A. H. Payne Transcription Enhancer Factor-5 and a GATA-Like Protein Determine Placental-Specific Expression of the Type I Human 3{beta}-Hydroxysteroid Dehydrogenase Gene, HSD3B1 Mol. Endocrinol., August 1, 2004; 18(8): 2049 - 2060. [Abstract] [Full Text] [PDF]

				L. Peng and A. H. Payne AP-2gamma and the Homeodomain Protein Distal-less 3 Are Required for Placental-specific Expression of the Murine 3beta -Hydroxysteroid Dehydrogenase VI Gene, Hsd3b6 J. Biol. Chem., March 1, 2002; 277(10): 7945 - 7954. [Abstract] [Full Text] [PDF]

				A. G. Mensah-Nyagan, J.-L. Do-Rego, D. Beaujean, V. Luu-The, G. Pelletier, and H. Vaudry Neurosteroids: Expression of Steroidogenic Enzymes and Regulation of Steroid Biosynthesis in the Central Nervous System Pharmacol. Rev., March 1, 1999; 51(1): 63 - 82. [Abstract] [Full Text] [PDF]

				T. M. Penning Molecular Endocrinology of Hydroxysteroid Dehydrogenases Endocr. Rev., June 1, 1997; 18(3): 281 - 305. [Abstract] [Full Text]